Manhattan oncology data company Flatiron Health said Thursday it has agreed to be acquired by the Swiss drugmaker Roche for $1.9 billion. The landmark deal signals the growing strength of the city's health technology sector.Original Article
Pharma giant Roche to acquire Flatiron Health for $1.9 billion
